Meeting Milestones and Patient Needs Through Expedited Delivery of Phase I Materials

Case study

In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines, and includes a one-month stability study.

Download this case study to learn how Reneo Pharmaceuticals was able to get to clinic in 14 weeks from delivery of their API with the Quick to Clinic™ for Oral Solid Dose program.